BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
3.600
-0.150 (-4.00%)
At close: Jul 22, 2026, 4:00 PM EDT
3.513
-0.087 (-2.41%)
After-hours: Jul 22, 2026, 7:34 PM EDT
BriaCell Therapeutics Market Cap
BriaCell Therapeutics has a market cap or net worth of $31.87 million as of July 22, 2026. Its market cap has increased by 490.22% in one year.
Market Cap
31.87M
Enterprise Value
9.21M
1-Year Change
490.22%
Ranking
Category
Stock Price
$3.60
ChartMarket Cap Chart
Since February 24, 2021, BriaCell Therapeutics's market cap has increased from $26.00M to $31.87M, an increase of 22.59%. That is a compound annual growth rate of 3.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 22, 2026 | 31.87M | 137.85% |
| Dec 31, 2025 | 13.40M | -46.40% |
| Dec 31, 2024 | 25.00M | -73.26% |
| Dec 29, 2023 | 93.50M | 37.91% |
| Dec 30, 2022 | 67.80M | -46.74% |
| Dec 31, 2021 | 127.30M | 389.62% |
| Feb 24, 2021 | 26.00M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nutriband | 37.44M |
| NanoViricides | 36.45M |
| Estrella Immunopharma | 34.43M |
| Lite Strategy | 34.03M |
| Aligos Therapeutics | 33.66M |
| Actuate Therapeutics | 32.30M |
| Serina Therapeutics | 31.34M |
| ABVC BioPharma | 31.08M |